Evidence map›Paper›PMID 37506069›Full record

ArticlePloS one2023

Validation of robust radiobiological optimization algorithms based on the mixed beam model for intensity-modulated carbon-ion therapy.

Masashi Yagi, Toshiro Tsubouchi, Noriaki Hamatani, Masaaki Takashina, Naoto Saruwatari, Kazumasa Minami, Yushi Wakisaka, Shinichiro Fujitaka, Shusuke Hirayama, Hideaki Nihongi and 5 more

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Masashi YagiDepartment of Carbon Ion Radiotherapy, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.ORCID 0000-0002-2827-5407
Toshiro TsubouchiDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka-shi, Osaka, Japan.
Noriaki HamataniDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka-shi, Osaka, Japan.
Masaaki TakashinaDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka-shi, Osaka, Japan.
Naoto SaruwatariDepartment of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Kazumasa MinamiDepartment of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Yushi WakisakaDepartment of Radiation Technology, Osaka Heavy Ion Therapy Center, Osaka-shi, Osaka, Japan.
Shinichiro FujitakaHitachi, Ltd., Research & Development Group, Hitachi-shi, Ibaraki, Japan.
Shusuke HirayamaHitachi, Ltd., Research & Development Group, Hitachi-shi, Ibaraki, Japan.
Hideaki NihongiHitachi, Ltd., Healthcare Innovation Division/Healthcare Business Division, Kashiwa-shi, Chiba, Japan.
Azusa HasegawaDepartment of Radiation Oncology, Osaka Heavy Ion Therapy Center, Osaka-shi, Osaka, Japan.
Masahiko KoizumiDepartment of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Shinichi ShimizuDepartment of Carbon Ion Radiotherapy, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Kazuhiko OgawaDepartment of Radiation Oncology, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Tatsuaki KanaiDepartment of Medical Physics, Osaka Heavy Ion Therapy Center, Osaka-shi, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, treatment planning systems (TPSs) that can compute the intensities of intensity-modulated carbon-ion therapy (IMCT) using scanned carbon-ion beams are limited. In the present study, the computational efficacy of the newly designed IMCT algorithms was analyzed for the first time based on the mixed beam model with respect to the physical and biological doses; moreover, the validity and effectiveness of the robust radiobiological optimization were verified. A dose calculation engine was independently generated to validate a clinical dose determined in the TPS. A biological assay was performed using the HSGc-C5 cell line to validate the calculated surviving fraction (SF). Both spot control (SC) and voxel-wise worst-case scenario (WC) algorithms were employed for robust radiobiological optimization followed by their application in a Radiation Therapy Oncology Group benchmark phantom under homogeneous and heterogeneous conditions and a clinical case for range and position errors. Importantly, for the first time, both SC and WC algorithms were implemented in the integrated TPS platform that can compute the intensities of IMCT using scanned carbon-ion beams for robust radiobiological optimization. For assessing the robustness, the difference between the maximum and minimum values of a dose-volume histogram index in the examined error scenarios was considered as a robustness index. The relative biological effectiveness (RBE) determined by the independent dose calculation engine exhibited a -0.6% difference compared with the RBE defined by the TPS at the isocenter, whereas the measured and the calculated SF were similar. Regardless of the objects, compared with the conventional IMCT, the robust radiobiological optimization enhanced the sensitivity of the examined error scenarios by up to 19% for the robustness index. The computational efficacy of the novel IMCT algorithms was verified according to the mixed beam model with respect to the physical and biological doses. The robust radiobiological optimizations lowered the impact of range and position uncertainties considerably in the examined scenarios. The robustness of the WC algorithm was more enhanced compared with that of the SC algorithm. Nevertheless, the SC algorithm can be used as an alternative to the WC IMCT algorithm with respect to the computational cost.

Indexed as

Heavy Ion RadiotherapyProton TherapyRadiotherapy, Intensity-ModulatedAlgorithmsCarbonRadiotherapy DosageRadiotherapy Planning, Computer-AssistedCarbon

Identifiers

PMID37506069
PMCPMC10381094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.